Literature DB >> 12641556

Distress, quality of life and strategies to 'keep a good mood' in patients with carcinoid tumours: patient and staff perceptions.

G Larsson1, K Haglund, L Von Essen.   

Abstract

Patients with carcinoid tumours have reported a relatively good health-related quality of life (HRQoL) (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30, EORTC QLQ-C30), and low levels of anxiety and depression (Hospital Anxiety and Depression Scale, HADS). The aim was to test the validity of these results. Data were gathered through interviews with 19 patients and 19 staff. Participants were asked about disease and treatment related distress, important aspects of quality of life and strategies to 'keep a good mood'. Patients were interviewed about themselves and staff were interviewed about a certain patient. Data were analysed by content analysis. Identified aspects of distress and quality of life were referred to an emotional, a physical and a social dimension. Most aspects of distress were of a physical character whereas most aspects of quality of life were of a social character. Several aspects of emotional distress not included in the EORTC QLQ-C30 and/or the HADS were identified.

Entities:  

Mesh:

Year:  2003        PMID: 12641556     DOI: 10.1046/j.1365-2354.2003.00322.x

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  7 in total

1.  Health-related quality of life, anxiety, depression and impulsivity in patients with advanced gastroenteropancreatic neuroendocrine tumours.

Authors:  Alexandra R Lewis; Xin Wang; Laurice Magdalani; Paolo D'Arienzo; Colsom Bashir; Was Mansoor; Richard Hubner; Juan W Valle; Mairéad G McNamara
Journal:  World J Gastroenterol       Date:  2018-02-14       Impact factor: 5.742

Review 2.  Somatically ill persons' self-nominated quality of life domains: review of the literature and guidelines for future studies.

Authors:  Elsbeth F Taminiau-Bloem; Mechteld R M Visser; Carol Tishelman; Margot A Koeneman; Florence J van Zuuren; Mirjam A G Sprangers
Journal:  Qual Life Res       Date:  2010-01-03       Impact factor: 4.147

3.  Validation of the EORTC QLQ-GINET21 questionnaire for assessing quality of life of patients with gastrointestinal neuroendocrine tumours.

Authors:  G Yadegarfar; L Friend; L Jones; L M Plum; J Ardill; B Taal; G Larsson; K Jeziorski; D Kwekkeboom; J K Ramage
Journal:  Br J Cancer       Date:  2013-01-15       Impact factor: 7.640

4.  Health related quality of life and psychosocial function among patients with carcinoid tumours. A longitudinal, prospective, and comparative study.

Authors:  Camilla Fröjd; Gunnel Larsson; Claudia Lampic; Louise von Essen
Journal:  Health Qual Life Outcomes       Date:  2007-04-11       Impact factor: 3.186

Review 5.  Quality of life, resource utilisation and health economics assessment in advanced neuroendocrine tumours: a systematic review.

Authors:  I Chau; R Casciano; J Willet; X Wang; J C Yao
Journal:  Eur J Cancer Care (Engl)       Date:  2013-07-29       Impact factor: 2.520

Review 6.  Systematic review reveals lack of quality in reporting health-related quality of life in patients with gastroenteropancreatic neuroendocrine tumours.

Authors:  Caroline Martini; Eva-Maria Gamper; Lisa Wintner; Bernhard Nilica; Barbara Sperner-Unterweger; Bernhard Holzner; Irene Virgolini
Journal:  Health Qual Life Outcomes       Date:  2016-09-10       Impact factor: 3.186

Review 7.  Health-Related Quality of Life (HRQoL) in Neuroendocrine Tumors: A Systematic Review.

Authors:  Rohit Gosain; Medhavi Gupta; Arya Mariam Roy; Jonathan Strosberg; Kathryn M Glaser; Renuka Iyer
Journal:  Cancers (Basel)       Date:  2022-03-10       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.